Hims & Hers Health Stock Drops 5.32% in Two Days Despite Strong Earnings and 22nd Rank in Trading Volume

On May 20, 2025, Hims & Hers Health (HIMS) experienced a 1.81% decline, marking its second consecutive day of losses, with a total decrease of 5.32% over the past two days. The trading volume for the day was 21.82 billion, placing it at the 22nd position in the daily stock market rankings.

Hims & Hers Health, Inc. (HIMS) has shown strong performance in recent earnings, with net income expanding by 346% to $49.5 million from $11.1 million in the same period last year. Revenues soared by 111% to $586 million from $278.2 million year-on-year. The company's strong performance has underpinned its updated 2025 guidance, with full-year revenues expected to settle between $2.3 billion and $2.4 billion, and the second quarter to end at $530 million to $550 million.

Hims & Hers Health, Inc. (HIMS) has a subscription model that ensures recurring revenue streams. The company reported a 38% increase in Q1 subscriber growth and targets an 85% long-term retention rate. This model is expected to benefit the company significantly in the long run.

Leerink Partners recently lifted their target price on shares of Hims & Hers Health from $24.00 to $40.00 and gave the company a "market perform" rating. This adjustment reflects the company's strong performance and potential for future growth.